Persistent pain, sensory disturbances, lymphedema and functional impairment are frequently occurring late effects of breast cancer treatment. The investigators have previously published data on 3253 women treated for breast cancer in Denmark in the period 2005-2006. Very few studies have examined how these late effects change in time. The aim of this study is to examine in a well defined patient population any change in the prevalence of persistent pain, sensory disturbances, lymphedema and functional impairment, as well as risk factor profile.
Study Type
OBSERVATIONAL
Enrollment
2,411
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Denmark
Prevalence of persistent pain
Prevalence of pain in the breast area, axilla, side of chest or arm, as a yes/no variable
Time frame: 6-7 years post operative
Prevalence of patients changing pain status from the 2008 survey
Time frame: 6-7 years
Prevalence of sensory disturbance
Time frame: 6-7 years
Prevalence of self reported lymphedma
Time frame: 6-7 years
Prevalence of functional impairment
Time frame: 6-7 years
Risk factors associated for persistent pain, sensory disturbances, lymphedema or functional impairment
Time frame: 6-7 years
Prevalence of patients changing status of sensory disturbances and self reported lymphedma
Time frame: 6-7 years
Risk factors associated to changing status of sensory disturbances and lymphedema
Time frame: 6-7 years post operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.